Therapeutic Area Digital Portfolio Lead For Global Medical & Global Product Launch Strategy
Current• Leading a major transformation initiative to rebuild Takeda’s CRM platform, shaping the future of HCP engagement through an insights-driven approach that aligns with the evolving needs of Medical Affairs and digital customer experience by 2030.• Collaborating with cross-functional teams across Medical, Commercial, and Global Digital & Data Technology (DD&T) to develop a roadmap that leverages AI and advanced analytics for optimized HCP engagement and patient experience.• Spearheading the design of an omnichannel ecosystem that integrates real-time physician feedback and new digital technologies to enhance physician satisfaction and streamline digital interactions.• Partnering across global, regional, and local to leverage digital marketing capabilities to deliver global brand strategic imperatives. • Leading strategic partnership between GPD DD&T and Gastrointestinal & Inflammation (GI&I) Therapeutic Area Unit (TAU), defining GI&I franchise launch strategy that merges digital with traditional methods to position Takeda for long-term market leadership. • Partnered with Entyvio (vedolizumab) Global Commercial Brand Team and regional franchise teams for Europe, Canada, Latin America, and Asia/Pacific to define ways of working to co-create and re-use marketing content and digital assets for the brand’s 2024 global campaign. • Established partnership with TAK-279 (zasocitinib) Global Product Strategy and Patient Health Excellence (PHE) to map patient solution ecosystem for immune-mediated inflammatory diseases, including psoriasis and psoriatic arthritis, to inform the digital product brand plan.